Repligen Corp (RGEN)
166.80
+1.98
(+1.20%)
USD |
NASDAQ |
May 10, 16:00
166.80
0.00 (0.00%)
After-Hours: 20:00
Repligen SG&A Expense (Quarterly): 60.99M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 60.99M |
December 31, 2023 | 57.51M |
September 30, 2023 | 55.46M |
June 30, 2023 | 48.97M |
March 31, 2023 | 56.17M |
December 31, 2022 | 53.24M |
September 30, 2022 | 53.64M |
June 30, 2022 | 54.65M |
March 31, 2022 | 54.30M |
December 31, 2021 | 52.06M |
September 30, 2021 | 48.37M |
June 30, 2021 | 44.34M |
March 31, 2021 | 39.10M |
December 31, 2020 | 36.34M |
September 30, 2020 | 29.05M |
June 30, 2020 | 26.73M |
March 31, 2020 | 27.50M |
December 31, 2019 | 28.29M |
September 30, 2019 | 24.63M |
June 30, 2019 | 23.70M |
March 31, 2019 | 19.00M |
December 31, 2018 | 17.34M |
September 30, 2018 | 15.86M |
June 30, 2018 | 16.59M |
March 31, 2018 | 15.90M |
Date | Value |
---|---|
December 31, 2017 | 16.14M |
September 30, 2017 | 15.00M |
June 30, 2017 | 11.18M |
March 31, 2017 | 9.182M |
December 31, 2016 | 8.567M |
September 30, 2016 | 7.127M |
June 30, 2016 | 8.14M |
March 31, 2016 | 7.018M |
December 31, 2015 | 6.473M |
September 30, 2015 | 5.959M |
June 30, 2015 | 6.242M |
March 31, 2015 | 6.026M |
December 31, 2014 | 4.974M |
September 30, 2014 | 4.471M |
June 30, 2014 | 4.326M |
March 31, 2014 | 3.384M |
December 31, 2013 | 3.367M |
September 30, 2013 | 2.902M |
June 30, 2013 | 3.124M |
March 31, 2013 | 3.308M |
December 31, 2012 | 3.254M |
September 30, 2012 | 3.126M |
June 30, 2012 | 3.418M |
March 31, 2012 | 3.428M |
September 30, 2011 | 2.493M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
23.70M
Minimum
Jun 2019
60.99M
Maximum
Mar 2024
43.75M
Average
48.67M
Median
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.694M |
Retractable Technologies Inc | 4.158M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |